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we explored the influence of the price of apixaban. Conclusions are clearly, 
highly dependent on the assumed price of apixaban for this indication. 
CONCLUSIONS: The results indicate that there is great uncertainty regarding 
which treatment is the cost-effective alternative. Given current evidence, it may 
be too early to conclude that the new oral anticoagulants are cost-effective 
compared to warfarin.  
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COST-EFFECTIVENESS MODELLING OF TELEMONITORING AFTER DISCHARGE 
FROM HOSPITAL WITH HEART FAILURE  
Thokala P, Brennan A, Baalbaki H 
University of Sheffield, Sheffield, UK  
OBJECTIVES: To estimate the cost-effectiveness of home telemonitoring (TM) or 
structured telephone support (STS) strategies versus usual care for adults recently 
discharged (within 28 days) after a heart failure (HF) exacerbation in England and 
Wales. METHODS: A Markov model was used to evaluate three interventions: 1) 
STS via human to machine (HM) interface; 2) STS via human to human (HH) 
contact; and 3) TM, against 4) usual care. Given heterogeneity in the interventions, 
cost-effectiveness analysis was performed using bottom up costing scenarios. Costs 
and quality adjusted life years (QALYs) over a 30-year horizon were estimated based 
on monthly probabilities of death and monthly risks of hospitalisations (HF-related 
complications or other causes) estimated from clinical effectiveness parameters 
computed using a network meta-analysis of randomised controlled trials. RESULTS: 
Base case monthly costs per patient were: £27 for usual care, £119 for STS HM, £179 
for STS HH and £175 for TM. TM was the most cost-effective strategy in the scenario 
using these base case costs. Compared with usual care, TM had an estimated 
incremental cost effectiveness ratio (ICER) of £9,552/QALY, whereas STS HH had an 
ICER of £63,240/QALY against TM. STS HM was dominated by usual care. 
Probabilistic sensitivity analysis (PSA) showed 44% chance of TM being cost-
effective with STS HH 36%, STS HM 18% and usual care 2%, respectively. Threshold 
analysis suggested that the monthly cost of TM has to be higher than £390 to have 
an ICER greater than £20,000/QALY against STS HH. Scenario analyses performed 
using higher costs of usual care, higher costs of STS HH and lower costs of TM do 
not substantially change the conclusions. CONCLUSIONS: Cost-effectiveness 
analyses suggest TM was an optimal strategy in most scenarios, but there is 
considerable uncertainty in relation to clear descriptions of the interventions and 
robust estimation of costs.  
 




ANALYSIS OF THE IMPACT OF PRESCRIPTION SYNCHRONIZATION ON 
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OBJECTIVES: A prescription synchronization and medication management 
program has been implemented in several community pharmacies to enhance 
medication adherence and provide greater efficiency in the pharmacy. The 
objectives of this analysis were to examine the impact of the program on chronic 
medication adherence and health care costs. METHODS: A cross-sectional 
analysis using Mississippi Medicaid claims from 2008-2011 was undertaken. 
Claims for three drug-classes including statins, antihypertensives, and oral 
hypoglycemics were extracted from a pharmacy that implemented the program 
and the other pharmacies serving patients in the same geographic area. First, a 
retrospective matched cohort analysis was undertaken to compare medication 
adherence measured as the proportion of days covered (PDC) and medical costs 
3, 6, 9, and 12 months from the index date. Patients in the two groups were 
matched on age, gender, and race using a greedy-match algorithm. Second, a 
pre-post analysis comparing medication adherence and costs was conducted 
before and after the enrolling in the target pharmacy program. RESULTS: In the 
matched analysis, the average PDC three months (90.87% vs. 84.27%; p=0.002) 
and six months (87.91% vs. 81.86%; p=0.01) after the index date was significantly 
higher in the target pharmacy group than in the other group. Average medical 
costs 3 months ($2,326.52 vs. $1,802.41; p<0.0001) and 12 months ($7,505.36 vs. 
$7,446.77; p=0.04) after the index date were significantly higher in the other 
pharmacy group than in the target pharmacy group. In the pre-post analysis, the 
average PDC before enrolling in the target pharmacy service was significantly 
lower than after enrollment (70.3% vs. 84.2%; p<0.0001). In addition, average 
medical costs per patient per month significantly reduced from $584 in the pre-
period to $420 in the post-period (p<0.0001). CONCLUSIONS: The new service 
was not only associated with improved medication adherence, but also with 
decreased medical expenditures among chronic patients.  
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OBJECTIVES: To understand current medication compliance status of 
hypertension and its associated factors in urban China. METHODS: A 
community-based hypertension health survey was conducted in 2 cities of China 
(Beijing and Hangzhou) from Nov 2011 to Aug 2012. 10 community health service 
centers in each city were selected through cluster sampling. Hypertension 
patients who registered in the study sites were recruited by field investigators 
using standardized questionnaires. Patient data were collected including socio-
demographic characteristics, disease profile, treatment pattern, and health 
education awareness. Medication compliance was assessed by Morisky score. 
Self-reported health utility and social support scale instruments were also 
employed. Logistic regression and multivariate analysis were used to explore the 
associated factors affecting medication compliance in hypertension. RESULTS: In 
total, 1006 patients with hypertension were included, with average age of 
65.26±11.27 years old. 40.85% were male. The average duration of hypertension is 
12.35±10.27 years. 761 patients (75.65%) managed to control blood pressure under 
140/90 mmHG based on last blood pressure detected. 89.76% of the study 
subjects had less than 3 complications. Results show that 67.1% subjects 
achieved high level of compliance, 25.94% were moderate compliant, and 6.96% 
were non-compliant. The main influential factors of non-compliance were 
forgetting to take medicine (57.1%) and self-awareness of disease remission 
(32.6%). Multivariate analysis showed that compliance was positively associated 
with age, disease duration and social support, while negatively associated with 
existence of hypertension complications. Household income and reimbursement 
status were not major factors affecting medication compliance. Patients with 
high level of compliance also reported to have better health utility scores. 
CONCLUSIONS: The compliance status in hypertension in urban China is 
relatively poor. Strengthening family support and implementing effective health 
are important to improve medication compliance in hypertension, which may 
lead to improved patient reported outcomes.  
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OBJECTIVES: Primary non-adherence occurs when a patient does not fill the 
prescription for a newly initiated medication. Contrary to the commonly 
researched concept of medication non-adherence (ie, secondary non-adherence), 
failure to start a new medication is less studied and can potentially pose a 
similar challenge to disease management. Our objective was to observe the 
primary non-adherence rate of newly initiated statins within 6 and 21 days of an 
electronic prescription. This study also explored differences in characteristics 
between primary adherent and non-adherent groups. METHODS: This was a 
retrospective observational study, using electronic prescriptions and pharmacy 
claims and sales records from Scott & White Health Plan (Temple, Texas, USA). 
Adult patients (n=2879) were included in the study if they had no prior exposure 
to any anti-hyperlipidemic drugs and received their first statin prescription from 
September 2009-May 2012. Outcomes measured included primary non-
adherence rates within 6 and 21 days after a new statin prescription was written. 
Characteristics (eg, age, gender, race, Charlson Comorbidity Index, prescriber 
type) were compared between adherent and non-adherent groups using 
descriptive statistics and logistic regression. RESULTS: The 6- and 21-day 
primary non-adherence rates were 29.2% and 21.7%, respectively. Logistic 
regression of 6-day primary adherence revealed that women were less likely to 
be non-adherent than men (OR: 0.815; 95% CI: 0.693–0.960), and African 
Americans were more likely than whites to be non-adherent (OR: 1.486; 95% CI: 
1.107–1.995). Patients were less likely to fill prescriptions written by allied health 
professionals than primary care providers (OR: 0.673; 95% CI: 0.465–0.974). 
CONCLUSIONS: This is one of the few studies to investigate primary non-
adherence in a real-world setting, and the results may be helpful in solving 
another piece of the overall non-adherence puzzle. Exploratory analysis 
indicated that male gender and African American race were predictors of 
primary non-adherence to statins.  
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OBJECTIVES: Despite the rising prevalence of hypertension and the availability 
of evidence-based guidelines for effective treatments, blood pressure (BP) control 
rates remain low. The purpose of this study was to evaluate the effect of 
telephone counseling intervention on blood pressure control. METHODS: Adults 
with hypertension attending the Centre for Diagnosis and Therapy of Arterial 
Hypertension of Cardarelli Hospital, Naples, Italy were randomly allocated to 
receive a pharmacist/counselor-administered counseling intervention (group I) 
or usual care (group C). Group I patients received the counseling intervention bi-
monthly for two years via telephone; the goal of the intervention was to promote 
medication adherence and improve hypertension-related health behaviors. The 
telephone intervention focused on perceived risk of hypertension and 
knowledge, memory, medical and social support, patients' relationship with 
their health care provider, adverse effects of medication therapy, weight 
management, exercise, diet, smoking, and alcohol use. BP values were registered 
at baseline, after one year and at the end of the investigation for both groups. 
Medication adherence (Belief Medicine Questionnaire, BMQ) was also assessed. 
Analysis was performed using SPSS version 19.0 RESULTS: Group I consisted of 
84 patients. A comparable sample was assigned to group C (n=80). The average 
phone call lasted 18 minutes (range 7 to 45 minutes). After two years there was a 
significant reduction of BP values for group I (t=0: Systolic=146.8±2.3 
Diastolic=90.2±4.2, t=24 months Systolic=138.4±4.6 Diastolic=86.9±3.8) (P<0.001). 
From baseline to two years, BMQ analysis showed an adherence improvement in 
group I (t=0 Necessity Score=15.6±3.5, concern Score=14.9±2.9, t=24 Necessity 
Score=22.4±2.4 and Concern Score=10±2.2). Group C did not show any 
statistically significant results. CONCLUSIONS: These findings suggest that 
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telephone counseling can significantly improve blood pressure control. Our data 
show also that interventions run by allied health professionals (i.e. other than 
the prescriber/doctor), improve adherence to medicines and promote 
hypertension-related health behaviors.  
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OBJECTIVES: To describe initially-prescribed drug treatments for hypertension in 
newly-diagnosed recipients in a Medicaid population and to determine factors 
affecting 6- and 12-month persistence rates. METHODS: This retrospective study 
included continuously-enrolled Louisiana Medicaid recipients aged 18-64 who 
were newly-diagnosed with hypertension between January 2006 and December 
2008. Dually-eligible recipients were excluded. Recipients were followed for one 
year after their index date. Initial drug therapy was described, and persistence 
rates were calculated 6- and 12-months post-index, for recipients who received 
diuretics, beta-blockers (BBs), angiotensin-II receptor blockers (ARBs), 
angiotensin converting enzyme inhibitors (ACEIs), and calcium channel blockers 
(CCBs). A 30-day grace period was allowed for refill gaps. Race, gender, age, and 
co-morbidity were used as predictor variables in logistic regression analyses of 
persistence for each drug class. RESULTS: A total of 4946 recipients were eligible 
for inclusion. Of these, 2352 received no drug therapy and 289 did not receive 
therapy in one of the analyzed drug classes, leaving a final study group of 2305 
recipients. The study group was primarily female (68%) and African-American 
(67%). The majority of recipients received diuretics, followed by ACEIs, ARBs, BBs, 
and CCBs. Persistence rates for initially-prescribed drugs ranged from 21.6% for 
diuretics to 31.6% for ACEIs at 6-months, and from 10.7% for diuretics to 17.9% 
for CCBs at 12-months. Within drug classes, persistence ranged from 24.2% for 
diuretics to 33.1% for ACEIs at 6-months and 12.4% for diuretics to 19.3% for BBs 
at 12-months. Race, gender, and age were significant factors predicting 
persistence, with African-Americans less persistent than Whites, females less 
persistent than males, and younger recipients less persistent than older 
recipients. CONCLUSIONS: Approximately half of newly-diagnosed recipients did 
not receive drug therapy, and among treated patients, persistence rates were 
poor. Race, gender, and age were factors influencing persistence of therapy in 
this study group.  
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THROMBOEMBOLISM PROPHYLAXIS: IMPLICATIONS FOR NOVEL 
INTERVENTION STRATEGIES  
Shermock KM1, Lau B2, Haut E3, Hobson D3, Ganetsky V4, Kraus P5, Efird L5, Elder S4,  
Pinto BL1, Streiff MB3 
1The Johns Hopkins Medical Institutions, Baltimore, MD, USA, 2Johns Hopkins University, 
Baltimore, MD, USA, 3The Johns Hopkins University School of Medicine, Baltimore, MD, USA, 
4Philadelphia College of Pharmacy, Philadelphia, PA, USA, 5The Johns Hopkins Hospital, 
Baltimore, MD, USA  
OBJECTIVES: Recent studies have documented high rates of non-administration 
of ordered venous thromboembolism (VTE) prophylaxis doses. Intervention 
strategies that target all patients have been effective, but prohibitively resource-
intensive. We aimed to identify efficient intervention strategies based on 
patterns of non-administration of ordered VTE prophylaxis. METHODS: In this 
retrospective review of electronic medication administration records, we 
included adult hospitalized patients who were ordered pharmacologic VTE 
prophylaxis with unfractionated heparin or enoxaparin over a seven-month 
period. The primary measure was the proportion of ordered doses of VTE 
prophylaxis not administered, assessed at the patient, floor, and floor type 
levels. Differences in non-administration rates between groups were assessed 
using generalized estimating equations. RESULTS: A total of 103,160 ordered VTE 
prophylaxis doses during 10,516 patient visits on twenty-nine patient floors were 
analyzed. Overall, 11.9% of ordered doses were not administered. Approximately 
19% of patients missed at least one quarter and 8% of patients missed over one 
half of ordered doses. There was marked heterogeneity in non-administration 
rate at the floor level (range: 5-27%). Patients on medicine floors missed a 
significantly larger proportion (18%) of ordered doses compared to patients on 
other floor types (8%, Odds Ratio: 2.4, p<0.0001). However, more than half of 
patients received at least 86% of their ordered doses, even on the lowest 
performing floor. The 20% of patients who missed at least two ordered doses 
accounted for 80% of all missed doses. CONCLUSIONS: A substantial proportion 
of ordered doses of VTE prophylaxis were not administered. The heterogeneity in 
non-administration rate between patients, floors, and floor types can be used to 
target interventions. The small proportion of patients that missed multiple 
ordered doses accounted for a large majority of non-administered doses. This 
recognition of the Pareto principle provides opportunity to efficiently target a 
relatively small group of patients for intervention.  
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OBJECTIVES: In 2007 the Work Group of Cardarelli Hospital (Naples, Italy) 
developed a therapeutic education program to reduce blood pressure (BP) in 
patients with hypertension through a better adherence to pharmacological and 
non pharmacological treatment. The program was funded by a grant from Italian 
Agency of Drugs (AIFA). The activity involved General Practitioners (GPs) from 
Campania region METHODS: The study was an experimental controlled trial 
with the enrolment of 2329 (1139 Intervention and 1190 Controls). Group 
Intervention (I) patients participated to 3 educational sessions (two focus group 
and one role play) respectively 2, 4 and 9 months after the recruitment. Group 
Control (C) patients received usual care. Blood pressure values were registered at 
the baseline and after 12 months. Focus groups are qualitative interviews with a 
small number of people brought together to discuss a host of topics under the 
guide of a "moderator". Role play is a simulation that reflects a situation found in 
the real world.The aim of role play is to learn how to perform the instructions 
and how to best handle a situation by practicing and interacting with people 
who share the same condition. Univariate General Linear models (GLM) were 
used to compare mean variation in systolic and diastolic blood pressure 
(SBP;DBP) between groups (Intervention and control) after adjusting for the 
covariates measured at baseline. RESULTS: Adjusted mean reduction of SBP was-
1.6mmHG 95% C.I [-6.3mmHG ; +3.1mmHG] in the intervention group and 
+0.8mmHG; 95% C.I [-3.9mmHG ; +5.4mmHG] in the control group. The different 
behavior of the two groups led to a significant treatment effect (Intervention vs 
Control) equal to-2.4mmHG,95% C.I [-3.4 mmHG ; -1.3mmHG]. CONCLUSIONS: 
Our findings show that a patient-oriented approach is a powerful tool for 
reaching better blood pressure control and underlying the essential role of 
patients involvement in the management of their care.  
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OBJECTIVES: A recent study at our institution indicated that 12.8% of all 
prescribed doses of venous thromboembolism (VTE) prophylaxis are not 
administered, with some nursing units approaching 30%. Our goal was to assess 
nursing beliefs and practices related to non-administration of ordered VTE 
prophylaxis doses. METHODS: We conducted a mixed-methods study, including 
qualitative observation and quantitative survey assessment. The study was 
conducted on twelve inpatient nursing units with disparate non-administration 
rates of ordered VTE prophylaxis doses of either unfractionated heparin or 
enoxaparin. Qualitative aspects of the nurse-patient encounter were directly 
observed by the lead investigator at the scheduled administration time of VTE 
prophylaxis until thematic saturation was achieved. A survey was distributed to 
all nurses on the included floors to identify beliefs and practices regarding non-
administration of ordered VTE prophylaxis doses. RESULTS: Low-performing 
units had an average pharmacologic VTE prophylaxis non-administration rate of 
18%, compared to the high-performing units which averaged a non-
administration rate of 10%. During observations, some nurses presented 
pharmacologic VTE prophylaxis to their patients as an optional therapy and 
entered into negotiations with their patients whereby patients could promise to 
walk to avoid a dose. Nurses on low-performing units were more likely to 
respond that VTE prophylaxis was prescribed for patients who do not require it 
(83% vs. 62%, p<0.0001) and were also more likely to believe that they had the 
clinical decision-making skills to determine when to omit unnecessary doses of 
prescribed VTE prophylaxis (80% vs. 50%, p<0.0001). Workload was not identified 
as a reason for non-administration on either high- or low-performing units. 
CONCLUSIONS: Nurses on low-performing units more often believe they have 
the skills to determine which patients require pharmacologic VTE prophylaxis 
and are more likely to present the medication as optional to patients. Strategies 
to improve administration rates should incorporate these findings.  
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OBJECTIVES: Adherence to medications (AM) has been a major research priority 
for recent decades. Numerous factors including poor access to medicines have 
been identified to affect AM particularly in middle income countries (MIC). 
However, access to medicines seems to be addressed well in Iran as a MIC but 
little is known about the rate and the determinants of AM for Iranian patients. In 
the present study, we systematically reviewed the AM literature related to 
Iranian patients with diabetes (DM) and cardiovascular diseases (CVD). 
METHODS: We searched biomedical databases including Scopus, Web of Science, 
PubMed, CINAHL, and Google Scholar, Scientific Information Database, and 
IranMedex from inception to July 2012. Two independent researchers screened 
all abstracts. Studies were included if they reported rate of adherence to CVD or 
DM medications in Iran. We also included studies which had focused on AM 
determinants or AM improving interventions. Two teams of researchers 
reviewed full-texts of the relevant articles for quality appraisal and data 
extraction. We preferred qualitative synthesis of literature as the AM definitions 
and measurement tools were highly diverse among studies. RESULTS: Among 
1003 citation, fourteen studies were eligible for review. Adherence rate for 
